Literature DB >> 16487803

Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.

David Beltran1, William C Faquin, George Gallagher, Meredith August.   

Abstract

PURPOSE: Polymorphous low-grade adenocarcinoma (PLGA) is a salivary gland malignancy characterized by indolent growth and a low rate of metastasis. PLGA shares histological features with adenoid cystic carcinoma (ACC), including infiltrating solid and cribriform patterns, presence of cystic spaces, and neurotropism. The degree of polymorphism of PLGA presents diagnostic challenges, particularly in small biopsy specimens. Immunohistochemical reactions to differentiate PLGA from the more aggressive ACC would be extremely valuable but controversy exists in the current literature regarding their utility. This study examines the potential use of c-kit, Ki-67, smooth muscle actin (SMA), and muscle-specific actin (MSA) as ancillary markers for distinguishing PLGA from ACC. PATIENTS AND METHODS: Medical records of 20 cases of PLGA treated at the Massachusetts General Hospital were reviewed. Patient demographic data and tumor-specific information were elicited. Formalin-fixed paraffin-embedded sections from 10 of these cases and 12 comparison cases of ACC were accessed. The histologic diagnoses were confirmed and immunohistochemical staining using antibodies to c-kit, Ki-67, SMA, and MSA was employed to determine differences in staining.
RESULTS: PLGA showed a significantly weaker immunohistochemical expression of c-kit compared with ACC (P = < .001). Ki-67, correlating with proliferative behavior, was more weakly expressed in PLGA (P = .091). The exuberant myoepithelial component of ACC resulted in stronger staining with SMA and MSA (P = .047; P = .065, respectively).
CONCLUSIONS: Statistically significant immunohistochemical staining patterns using c-kit and SMA in this study support their potential use as markers to differentiate PLGA from ACC in cases where the diagnosis can be challenging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487803     DOI: 10.1016/j.joms.2005.11.027

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  16 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

2.  SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma.

Authors:  Brian D Adkins; Ariana Geromes; Lily Y Zhang; Rebecca Chernock; Katherine Kimmelshue; James Lewis; Kim Ely
Journal:  Head Neck Pathol       Date:  2019-06-20

3.  Polymorphous low-grade adenocarcinoma of maxillary alveolus metastasising to the abdomen: the role of immunomarkers in diagnosis.

Authors:  Aatish Thennavan; Lakshmi Rao; Raghu Radhakrishnan
Journal:  BMJ Case Rep       Date:  2013-05-08

4.  Polymorphous Low-Grade Adenocarcinoma (PLGA) in an 18-Year-Old Male.

Authors:  Mridula Shukla; Umakant Gaud; Mohan Kumar; Manoj Pandey
Journal:  Indian J Surg       Date:  2013-01-19       Impact factor: 0.656

5.  Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Authors:  Stephan Schwarz; Maximilian Müller; Tobias Ettl; Philipp Stockmann; Johannes Zenk; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2011-04-18

6.  Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.

Authors:  Lisa Rooper; Rajni Sharma; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2014-06-27

Review 7.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

8.  Immunohistochemical clue for the histological overlap of salivary adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Authors:  Sherif El-Nagdy; Naglaa M Salama; Mohamed I Mourad
Journal:  Interv Med Appl Sci       Date:  2013-09-16

9.  Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases.

Authors:  Justin A Bishop; Dipti P Sajed; Ilan Weinreb; Brendan C Dickson; Elizabeth A Bilodeau; Abbas Agaimy; Alessandro Franchi; Syed Ali Khurram; Philip Da Forno; Juliana Robledo; John R Kalmar; Sarah Aguirre; Jeffrey F Krane; Jose Luis Tapia; Katalin Kiss; Kitrina Cordell; Molly Rosebush; A William Barrett; Dolphine Oda; Adel Assaad; Toshitaka Nagao; Fumi Kawakami; Masato Nakaguro; Ismail Zahir; Kristina Wakeman; Stephan Ihrler; Jacinthe Chenevert; Yi-Ling Lin; William H Westra; Jeffrey Gagan; Lisa M Rooper
Journal:  Head Neck Pathol       Date:  2021-05-12

Review 10.  Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists.

Authors:  Vera Cavalcanti de Araujo; Fabricio Passador-Santos; Cecilia Turssi; Andresa Borges Soares; Ney Soares de Araujo
Journal:  Diagn Pathol       Date:  2013-01-15       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.